Publication: Use of Norplant® implants in asymptomatic HIV-1 infected women
Issued Date
1997-04-01
Resource Type
ISSN
00107824
Other identifier(s)
2-s2.0-0030610301
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Contraception. Vol.55, No.4 (1997), 205-207
Suggested Citation
Surasak Taneepanichskul, Suwachai Intaraprasert, Winit Phuapradit, Kamhaeng Chaturachinda Use of Norplant® implants in asymptomatic HIV-1 infected women. Contraception. Vol.55, No.4 (1997), 205-207. doi:10.1016/S0010-7824(97)00011-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/18145
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Use of Norplant® implants in asymptomatic HIV-1 infected women
Other Contributor(s)
Abstract
The study of Norplant® implants use in HIV-1 infected women was conducted at the Family Planning Clinic, Department of Obstetrics and Gynaecology, Faculty of Medicine, Ramathibodi Hospital Mahidol University, Bangkok, Thailand, from January 1993 to June 1996. The purpose of the study was to evaluate efficacy, clinical effects, side effects, and menstrual patterns of the Norplant system in HIV-1 infected acceptors. Forty-one cases of asymptomatic HIV-1 positive women voluntarily participated in using Norplant implants after delivery or abortion. The mean age was 25.4 years: The most common menstrual pattern was irregular bleeding (63.4%). Mean blood pressure, body weight, and hemoglobin level were not different at insertion and at 12 months (p > 0.05). No pregnancy occurred during a 12-month period. It was concluded that the Norplant system was safe, efficacious, and well tolerated in HIV-1 positive women and is an appropriate contraception in these women.